STOCK TITAN
  1. Home
  2. Sec-filings
  3. ERNA
  4. [CERT] Ernexa Therapeutics Inc. Certification Filing

[CERT] Ernexa Therapeutics Inc. Certification Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
CERT
CERT - Ernexa Therapeutics Inc.

CERT Filing - Ernexa Therapeutics Inc.

This filing is available as a PDF document.

Filing Type: CERT

Company: Ernexa Therapeutics Inc. (ERNA)

Acceptance Date: 2026-02-05T15:11:47.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Ernexa

NASDAQ:ERNA

View ERNA Stock Overview →

ERNA Rankings

#6582 Ranked by Market Cap
N/A Ranked by Dividends

ERNA Latest News

Feb 20, 2026
Ernexa Therapeutics to Participate in Virtual Investor Closing Bell Series
Feb 6, 2026
Ernexa Therapeutics Announces Pricing of $10.5 Million Public Offering
Feb 3, 2026
Ernexa Therapeutics Participates in Virtual Investor “What This Means” Segment Highlighting Recent Successful Pre-IND Meeting with U.S. FDA
Jan 27, 2026
Ernexa Therapeutics Selected as One of Only Ten Global Companies for Prestigious JETRO Japan Entry Acceleration Program
Jan 6, 2026
Ernexa Therapeutics Announces Successful Pre-IND FDA Meeting and Continues Progress Toward First-in-Human Trial in Ovarian Cancer

ERNA Latest SEC Filings

Mar 24, 2026
[S-3/A] Ernexa Therapeutics Inc. Amended Shelf Registration Statement
Mar 20, 2026
[8-K] Ernexa Therapeutics Inc. Reports Material Event
Mar 13, 2026
[S-3] Ernexa Therapeutics Inc. Shelf Registration Statement
Mar 13, 2026
[10-K] Ernexa Therapeutics Inc. Files Annual Report
Feb 26, 2026
[8-K] Ernexa Therapeutics Inc. Reports Material Event

ERNA Stock Data

6.85M
19.67M
Biotechnology
Pharmaceutical Preparations
Link
United States
CAMBRIDGE